Policy / Regulatory

China Opens Doors to Foreign Biotech and Wholly-Owned Hospitals in Healthcare Sector Expansion

Company

Connect Biopharma Shifts Focus to US, Plans Further Reduction in China Workforce

Policy / Regulatory

Guangzhou Health Commission Unveils Ten Measures to Boost Innovative Pharma and Medical Device Development

CompanyDrug

Merck and Daiichi Sankyo’s Ifinatamab Deruxtecan Shows Promising Results in Phase II ES-SCLC Trial

CompanyPolicy / Regulatory

Biosecure Act Faces Opposition from Senior House Democrat Jim McGovern

CompanyDrug

China’s CDE Releases 86th Batch of Reference Preparations for Generic Drug Evaluation

CompanyDrug

Akeso’s Ivonescimab Shows Promising Results in Phase III Clinical Trial for Hepatocellular Carcinoma

CompanyLegal / IP

AstraZeneca Faces Investigation in China Over Data Privacy and Unapproved Drugs

CompanyPolicy / Regulatory

U.S. House of Representatives to Review the Biosecure Act Amid Legislative Hurdles

CompanyDeals

Eli Lilly Partners with Genetic Leap for RNA-Targeted AI Drug Discovery

Company

Euroapi to Downsize API Production, Citing Asian Competition and Market Stagnation

CompanyDeals

Rigel Pharmaceuticals Strikes Deal with Kissei for Development and Commercialization of Rezlidhia in East Asia